Business
Raising Cane's logo in New York (Jeff Schear/Getty Images)
Raising Cane's logo in New York (Jeff Schear/Getty Images)
Weird Money

Raising Cane’s founder makes hundreds of millions in dividends

Not raising much outside capital has its benefits, such as nine-figure dividend payments.

Jack Raines

If you spend too much time in the tech/venture capital echo chamber, you may think that an entrepreneur’s only path to becoming rich is to raise venture funding, scale a tech startup to tens of millions in revenue, and sell to a big tech company. While, yes, this is one way to get rich, and it’s a common way to get rich in Silicon Valley, it’s far from the only way to get rich from an entrepreneurial venture.

In other parts of the country, like, say, Louisiana, a more efficient way to become rich might be to borrow a small business loan from a bank, open a restaurant that only sells chicken fingers and french fries, expand its presence, and, 28 years later, pay yourself a cool $200 million dividend each year. And that is precisely what Raising Cane’s CEO and founder, Todd Graves, has done.

On Tuesday, Bloomberg reported that Raising Cane’s, the popular chicken finger restaurant chain, sold a $500 million leveraged loan, its second bond offering in the last year, and it cited a report from S&P Global saying the company may use the proceeds to pay down $354 million of borrowings under its existing $1.2 billion revolving credit facility.

Cool, this is all pretty normal stuff: issuing new debt, typically with later maturity, to help pay down existing debt. What stood out to me was that S&P Global also noted that Raising Cane’s maintains “an aggressive growth and dividend policy,” and its stable outlook on the newly-raised BB debt “reflects our expectation for continued strong sales and EBITDA growth with a high level of cash outlay for capex and dividends.”

Who is receiving these high dividends? Raising Cane’s shareholders. Who happens to own 90% of the company’s equity? According to Bloomberg, it’s Graves. I was curious just how much money Graves might be making in dividends, and S&P Global left some clues in its note on Raising Cane’s debt issuance from October 2023.

“The company is majority owned by its founder and historically distributes discretionary dividends that have averaged about 20% of operating cash flow over the past four years. We expect returns will continue at this level but believe the company would curtail distributions if warranted.

Last year, Bloomberg reported that Raising Cane’s had paid total dividends of $183 million in fiscal years 2020 to 2022, with revenues of $1.5 billion, $2.2 billion, and $3.1 billion in each year, respectively. With the S&P noting that Raising Cane’s had paid out dividends averaging 20% of operating cash flow over the last four years, we can infer that total operating cash flow from 2020 to 2022 was ~$915 million ($183 million / 20%). If we assume that operating margins have remained consistent over time, they would average out to be 13.46% of revenue.

Bloomberg also reported that Raising Cane’s revenue was up 33% year over year through June of 2024, with the chicken chain generating $2.3 billion, compared to $1.7 billion in the first six months of 2023, and $1.2 billion of that came from Q2. If Raising Cane’s maintained that same revenue figure for the second half of 2024, hitting $4.6 billion in total revenue, and operating margins remained consistent, the company would be on pace for ~$619 million in operating cash flow and a $124 million dividend, of which Todd Graves would take home 90%.

Because Raising Cane’s is private, we can’t see the company’s full operating costs, but given its margins and dividend payouts in 2020 through 2022, as well as the S&P’s outlook that the company will continue high cash outlay for “capex and dividends,” I think it’s safe to assume that we’re directionally accurate.

While fried chicken isn’t as glamorous as artificial intelligence, it does come with one big positive: by raising less outside capital and retaining control of the company’s equity, founders can pay themselves fat dividends if the business pays out. Hence, Todd Graves is now worth $10 billion.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.